Regenerative Medicine Market orecast to 2030: Industry Insights by Top Key Players Novartis AG, Vericel Corporation, MiMedx, Stryker
Market Industry Reports (MIR) has published a new report titled “Regenerative Medicine Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global regenerative medicine market was estimated to be over US$ 13 billion in 2019. It is anticipated to grow at a CAGR of 23.2%from 2019 to 2030.
Some of the prominent players in the global regenerative medicine market include:
Novartis AG,
Integra LifeSciences Corporation,
Vericel Corporation,
MiMedx, Stryker,
Spark Therapeutics, Inc.,
Osiris Therapeutics, Inc.,
Kite Pharma,
Organogenesis Inc. and MEDIPOST among others.
Integra LifeSciences Corporation,
Vericel Corporation,
MiMedx, Stryker,
Spark Therapeutics, Inc.,
Osiris Therapeutics, Inc.,
Kite Pharma,
Organogenesis Inc. and MEDIPOST among others.
Click Here to Get Acess of Free Sample Pages @
https://www.marketindustryreports.com/pdf/254
https://www.marketindustryreports.com/pdf/254
Scope of Report:
The significant growth of the market can be attributed to increasing prevalence of chronic as well as genetic disorders followed by increasing demand of medicines and therapies that can help cure and prevent these disorders. Moreover, increasing private and government investments for research & development of regenerative medicines are anticipated to boost the regenerative medicine market over the forecast period. To obtain better insights regarding the market scenario, prominent players are increasingly focusing on mergers, acquisitions or collaborations with smaller regenerative medicine companies. For instance, in Jan 2020, Amgen announced a strategic collaboration with BeiGene a biopharmaceutical company focused on developing molecularly targeted and immuno-oncology drugs for the treatment of cancer. This strategic collaboration will enable Amgen to expand its oncology presence in China.
In recent years, prevalence and incidences of chronic infectious diseases as well as genetic disorders is increasing. For instance, according to American Cancer Society, in 2019, there were around 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States. Such high incidence rates are thus increasing the demand of medicines that can help to prevent or cure such diseases. Such factors are expected to play a pivotal role in fueling the growth of the market during the forecast period.
To Avail Limited Offers Get Interesting Discount @ https://www.marketindustryreports.com/discount/254
Segmentation:
Regenerative Medicine Market By Type: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineering Products and Gene Therapy Products
Application: Musculoskeletal Disorders, Oncology, Ocular Disorders, Wound Care and Diabetes
READ MORE INFORMATION @ http://xherald.com/news/regenerative-medicine-market-to-observe-rugged-expansion-at-a-cagr-of-23-2-by-2030-top-companies-novartis-ag-vericel-corporation-mimedxstryker/
Comments
Post a Comment